What is Vertex Pharmaceuticals's loss contingency accrual?

Vertex Pharmaceuticals (VRTX) reported loss contingency accrual of $0.00 in Q1 2026.

What does loss contingency accrual mean?

The amount of money the company has set aside on its balance sheet to cover probable legal or regulatory losses.

Discontinued — last reported Q2 '21

This is a positive signal — lower values indicate better performance for this metric.

StatementBalance Sheet Statement

SectionOther

CategoryRisk

SignalLower is better

VolatilityVolatile

First reportedQ4 2015

Last reportedQ2 2021

An increase suggests rising legal or regulatory risks, while a decrease indicates the resolution or reduction of previously identified contingencies.

This represents the amount of liabilities recorded on the balance sheet for legal or regulatory matters where a loss is...

Standard accounting practice for loss contingencies; peers disclose this in legal proceedings footnotes.

Metric ID: other_loss_contingency_accrual_at_carrying_value

2 periods

	Q4 '25	Q1 '26
Value	$0.00	$0.00

Range$0.00 – $0.00

What is Vertex Pharmaceuticals's loss contingency accrual?: Vertex Pharmaceuticals (VRTX) reported loss contingency accrual of $0.00 in Q1 2026.
What does loss contingency accrual mean?: The amount of money the company has set aside on its balance sheet to cover probable legal or regulatory losses.